LADENBURG THALMANN FINANCIAL SERVICES INC. - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 161 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$1,000
-88.9%
294
-83.4%
0.00%
Q3 2019$9,000
-10.0%
1,772
-1.5%
0.00%
Q2 2019$10,000
+25.0%
1,799
-1.3%
0.00%
Q1 2019$8,0000.0%1,823
-0.3%
0.00%
Q4 2018$8,000
-38.5%
1,828
-8.1%
0.00%
Q3 2018$13,000
-31.6%
1,990
-18.1%
0.00%
Q2 2018$19,0000.0%2,4300.0%0.00%
Q1 2018$19,000
+11.8%
2,430
-8.2%
0.00%
Q4 2017$17,0000.0%2,646
+20.0%
0.00%
Q3 2017$17,0000.0%2,205
-9.1%
0.00%
Q2 2017$17,000
-79.5%
2,426
-72.4%
0.00%
-100.0%
Q1 2017$83,000
+9.2%
8,7800.0%0.00%0.0%
Q4 2016$76,000
+216.7%
8,780
+134.2%
0.00%
Q3 2016$24,000
+100.0%
3,749
+33.0%
0.00%
Q2 2016$12,000
+500.0%
2,819
+493.5%
0.00%
Q1 2016$2,000
-33.3%
4750.0%0.00%
Q4 2015$3,0000.0%4750.0%0.00%
Q3 2015$3,000
-62.5%
475
-59.6%
0.00%
Q2 2015$8,000
+60.0%
1,175
+46.9%
0.00%
Q1 2015$5,000
-16.7%
8000.0%0.00%
Q4 2014$6,000
+100.0%
800
+44.4%
0.00%
Q3 2014$3,0005540.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Broadfin Capital, LLC 8,951,169$54,871,0003.38%
Virtus ETF Advisers LLC 103,807$636,0001.75%
BKS ADVISORS, LLC 291,150$1,785,0000.92%
Piermont Capital Management Inc. 363,549$2,229,0000.71%
TUDOR INVESTMENT CORP ET AL 2,370,760$14,532,0000.41%
SEARLE & CO. 60,000$349,0000.34%
TURNER INVESTMENTS LLC 252,785$1,550,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 891,672$5,466,0000.31%
Phocas Financial Corp. 635,333$3,895,0000.30%
TFS CAPITAL LLC 398,283$2,441,0000.26%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders